Self-Identification Program

Launched by UNIVERSITY HOSPITAL, MONTPELLIER · Dec 13, 2023

Keywords

ClinConnect Summary

This clinical trial, called the Self-Identification Program, is exploring a new approach to help people with Major Depressive Disorder feel better. The study will compare two different types of therapy: one focuses on helping individuals understand themselves better (a deeper level of Cognitive Behavioral Therapy, or CBT), while the other uses Acceptance and Commitment Therapy (ACT), which is a well-known method for managing thoughts and feelings. Researchers want to see if the new therapy leads to a significant improvement in symptoms right after treatment and if it helps prevent relapse six months later.

To participate, individuals must be between 18 and 70 years old and currently experiencing a major depressive episode. However, those with certain conditions, such as severe suicidal thoughts, psychotic disorders, or who are unable to give informed consent, will not be eligible. Participants can expect to engage in therapy sessions designed to improve their mental health and overall functioning, with the goal of reducing feelings of distress and improving their quality of life. The trial is not yet recruiting, so interested individuals should stay tuned for updates on when they can apply.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged 18 to 70 years, presenting a current major depressive episode (according to DSM 571), as part of unipolar or bipolar depressive disorder
• Exclusion Criteria:
• • Patients with a psychotic disorder
• • Patients with active thoughts of suicide with intention to carry out the act (C-SSRS "ideation suicidal" in the last week ≥ 4)
• • Inability to receive informed information about the study
• • Exclusion period determined by a previous study
• • Adult protected by law or patient under guardianship or curatorship
• • Not be affiliated to a French social security scheme or beneficiary of such a scheme
• • Not being able to give informed written consent
• • Pregnant or breastfeeding women
• • Patients under judicial protection